Business news – Page 63
-
BusinessUS senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
ResearchWorld's first commercial MOF keeps fruit fresh
Packaging releases plant growth regulator that slows down ripening
-
BusinessAcquisition spree moves Allergan towards innovative drugs
Company acquires five companies in six weeks across three disease areas
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
OpinionSlimmer synthesis
Atom economy is a noble aim, but there are other routes to efficient molecule making
-
BusinessJ&J to buy Abbott Medical Optics
Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business
-
BusinessDanaher boosts diagnostics with Cepheid buyout
$4bn deal strengthens Danaher’s life sciences portfolio
-
NewsGlyphosate ‘not likely’ to be carcinogenic
US environmental agency issues finding that the herbicide is unlikely to cause cancer, months after accidentally posting report online
-
BusinessFDA’s first Duchenne drug approval reveals schism
Oligonucleotide drug reaches market amid pressure from patient families and strife over ‘patient-focused drug development’ at the regulator
-
BusinessFertiliser firms Agrium and PotashCorp to merge
Canadian combination will create one of the largest crop nutrient companies in the world.
-
BusinessBayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
BusinessAtanor chemical plant in Argentina shuttered
Toxic releases have led to the indefinite closure of the facility after a decade-long legal fight
-
BusinessBrexit could push Japanese pharma out of the UK
Warnings that Japanese R&D investment in the UK is endangered by plans to leave the EU
-
-
BusinessSadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
BusinessHealthcare firms invest in Crispr gene editing technology
Crispr licence agreements open up opportunities in drug discovery
-
BusinessNovartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
BusinessUS government agency awards Monsanto whistleblower $22 million
Pay-out is second largest reward from US whistleblower programme
-
-
BusinessJoined-up thinking
The rift between contract medicinal chemistry and chemical development needs to be bridged